JSR Corp (4185.T)

4185.T on Tokyo Stock Exchange

11:30am IST
Change (% chg)

¥-46 (-1.87%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Monday, 1 Aug 2016 

ARAKAWA CHEMICAL INDUSTRIES <4968.T>:Says it will buy OPSTAR ( functional coating materials) business from JSR Corp <4185.T>, effective Oct. 1.  Full Article

R&I affirms JSR Corp's rating at "AA-" and changes outlook to negative from stable -R&I
Friday, 15 Jul 2016 

JSR Corp <4185.T> : Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I .Rating outlook changed to negative from stable.  Full Article

JSR Corporation reaches basic agreement with Ube Industries and Mitsubishi Rayon to start negotiation for merger of units in ABS resin business
Monday, 9 May 2016 

JSR Corporation <4185.T> and Ube Industries <4208.T> : Says JSR's wholly owned unit TPC to merge with UMG ABS, which is a JV of Ube Industries and Mitsubishi Rayon .Says the parties to sign agreement on Oct. 31 and merger effective Oct. 1, 2017.  Full Article

JSR to adopt International Financial Reporting Standards
Monday, 25 Apr 2016 

JSR CORP:Says to apply International Financial Reporting Standards (IFRS) as the new accounting method, to replace the current Japanese Accounting Standards.IFRS effective from July, 2017, when disclosing the financial report for Q1 of FY ending March 2018.  Full Article

JSR CORP establishes JSR Life Sciences Division
Monday, 18 Apr 2016 

JSR CORP:Says formation and establishment of its Life Sciences Division, JSR Life Sciences.  Full Article

JSR lowers consolidated full-year outlook for FY 2016
Monday, 11 Apr 2016 

JSR CORP:Says the company lowered the consolidated full-year outlook for revenue to 385,000 mln yen from 400,000 mln yen for the fiscal year ended March 31, 2016.Sees a decrease of operating profit forecast to 34,000 mln yen from 41,000 mln yen.Sees a decrease of ordinary profit forecast to 33,000 mln yen from 39,500 mln yen.Sees a decrease of net profit forecast to 24,000 mln yen from 30,000 mln yen.Sees a decrease of earnings per share to 105.57 yen from 131.06 yen.Comments the decreased sale volume, sluggish market condition and deteriorating margins in elastomer business and extraordinary loss recorded as impairment loss are the main reasons for the forecast.  Full Article

BRIEF-Crown Bioscience International to be JSR's wholly owned unit

* Says co plans to sign agreement and plan of merger with Gallo Merger Sub Corp and JSR Corporation